Since MASL can survive gastrointestinal proteolysis to remain biologically active in the circulatory system, it is able to inhibit melanoma cell migration when fed to mice and inhibit melanoma growth from inoculated B16 melanoma cells by reducing tumor vascularization [91]. The gene discussed is MAS1L; the disease is melanoma.